Human mesenchymal stem cells (MSCs) are multipotent stem cells, able to differentiate into multiple mesenchymal lineages. [1] [2] [3] Previously, we have shown that human fetal lung-derived MSCs enhance the engraftment of human umbilical cord blood (UCB)-derived CD34 ϩ hematopoietic cells in nonobese diabetic-severe combined immunodeficiency mice. 1 Here we show that secondtrimester amniotic fluid is an abundant source of fetal MSCs that exhibit a phenotype and multilineage differentiation potential similar to that of postnatal bone marrow (BM)-derived MSCs. We suggest that amniotic fluid is an attractive source of MSCs for cotransplantation in conjunction with UCB-derived hematopoietic stem cells.
Cotransplantation of UCB and haploidentical MSCs derived from parental BM is proposed as a strategy to reduce the delay in engraftment that is associated with UCB transplantation. The presence of MSCs in second-trimester amniotic fluid enables the possibility of cotransplantation of hematopoietic stem cells and MSCs from the same donor. This could be particularly useful in the setting of UCB transplantation between siblings. Split NA R FISH analysis was sequentially performed on the same mitosis with mixed Human BAC Clone GS119p5 and Clone GSI-552A1 (encompassing intron 1, exon 1, and 178 kbp upstream of the coding sequence of the CDK6 gene; Incyte Genomics, San Francisco, CA) and with IgH probes (Vysis, Downers Grove, IL) or Ig probes (kindly provided by Reiner Siebert). The CDK6 gene was split between chromosomes 7 and 22 in FIO, between chromosomes 7 and 14 in DUP, and between chromosomes 2 and 7 in LAN. Ig and IgH involvement was further demonstrated in patients 1 and 2, respectively. It may be noticed that the CDK6 GS119p5 probe gave a slight cross-hybridization with 3q chromosome. Southern blot analyses were performed with WS2 probe 4 and with CDK6 PCR-amplified cDNA probes: E1 (nucleotides 12 to 298; GenBank accession no. X66365), p123, and p45 (nucleotides 446 to 860 and 61817 to 62434, respectively; GenBank accession no. AC002454). Restriction mapping allowed us to locate the breakpoint in patients 1 and 3 inside the breakpoint cluster region previously described within a 3.6 kbp upstream of the transcriptional start site of CDK6. 2 As no mitosis was available for FISH analysis in LAN, Ig light chain locus involvement was confirmed by Southern blot analysis showing the cohybridization of the CDK6 rearranged band with the Ig probe (J).
SB indicates Southern blot; R, rearranged; and NA, not available. 
